This clinical trial tests how well a breast CT scan works to improve lesion detection for women undergoing breast screening. The breast CT device takes multiple pictures of the breast and creates a 3-D image of the breast. This may help doctors to see the small structures in breast tissue more clearly and may give a more accurate diagnosis of cancer. This is important because 25% to 35% of structures that do not appear to be normal and are removed (biopsied) for studying under a microscope turn out to be cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03954431.
Locations matching your search criteria
United States
Arizona
Tucson
Banner University Medical Center - TucsonStatus: Active
Contact: Srinivasan Vedantham
PRIMARY OBJECTIVE:
I. To determine if, at mean glandular radiation dose (MGD) suitable for screening, dedicated breast computed tomography (CT) (BCT) without intravenously administered contrast media (i.e., non-contrast scans) will improve lesion detection and diagnosis compared to the standard 2-view digital breast tomosynthesis (DBT) with synthesized mammography (SM).
OUTLINE:
Patients undergo bilateral breast CT scan, over approximately 10 seconds for each breast, for a total of less than 5 minutes. If a lesion or additional findings are identified, patients may also undergo standard of care ultrasound, magnetic resonance imaging (MRI) and/or biopsy.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationBanner University Medical Center - Tucson
Principal InvestigatorSrinivasan Vedantham
